AVXL as of Nov 1 · 16:59 ET
AVXLNasdaqBiological Products, (No Diagnostic Substances)
Anavex Life Sciences Corp. · Brief
Next report
23 days
Nov 24 · before openest.Q4 FY26
Expected move
No implied move.
0 of 5≥ implied
- avg implied
- ±35.6%
- avg realized
- ±9.2%
May 9 '24±24.8%▲+4.58%×0.18
Q1 FY26±35.0%▲+12.34%×0.35
Feb 9 '26±21.1%▲+6.10%×0.29
Q3 FY26±73.2%▲+8.43%×0.12
Aug 25 '26±24.1%▲+14.47%×0.60
quarterimplied−75%0+75%realized×
Aug '26±24.1%▲+14.47%×0.60
Q3 FY26±73.2%▲+8.43%×0.12
Feb '26±21.1%▲+6.10%×0.29
Q1 FY26±35.0%▲+12.34%×0.35
May '24±24.8%▲+4.58%×0.18
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 24 report · est.Bull2
Bear2 of 3
−3.84%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
AVXL report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.